R REMEGEN
Live / Registered — Registered (as of 29 Nov 2022)
What this means for you
Registered since 29 Nov 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79312573
- Registration number
- 6908910
- Mark type
- Design + words
- Filed
- 07 Apr 2021
- Published for opposition
- 13 Sept 2022
- Registered
- 29 Nov 2022
- Attorney of record
- Scott Sisun
Goods and services
- Class 005 — Pharmaceuticals: Human drug for the treatment of eye diseases; anticancer drug preparations; biological preparations for the treatment of cancer; pharmaceuticals used to treat cancer; medical immunoassay reagent preparations; a medicinal preparation used to treat diseases and disorders related to the immune system
Owner
- RemeGen Co., Ltd., CN
- RemeGen Co., Ltd., CN
- RemeGen Co., Ltd., CN
Prosecution history
- 12 Apr 2023 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 16 Mar 2023 — FINAL DISPOSITION NOTICE SENT TO IB
- 16 Mar 2023 — FINAL DISPOSITION PROCESSED
- 28 Feb 2023 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 29 Nov 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 29 Nov 2022 — REGISTERED-PRINCIPAL REGISTER
- 27 Nov 2022 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 09 Nov 2022 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 09 Nov 2022 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 03 Oct 2022 — NOTIFICATION PROCESSED BY IB
- 13 Sept 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Sept 2022 — PUBLISHED FOR OPPOSITION
- 07 Sept 2022 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 07 Sept 2022 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 24 Aug 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED